AnaptysBio Announces Appointment of Oleg Nodelman to Board of Directors

NEXT STORY
Replimune to Present New Biomarker & Pre-clinical Data for Lead Oncolytic Immunotherapy Programs at the 2021 American Association for Cancer Research Annual Meeting
PREV STORY
BriaCell Announces Closing of Over-Allotment Option in Connection with U.S. Public Offering, Bringing Total Gross Proceeds to US$28.7 Million
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News

Amolyt Pharma Doses First Subject in Phase 1 Clinical Trial of Parathyroid Hormone Analog, AZP-3601, for Hypoparathyroidism

author_avatar
NASDAQ Market News

Project HOPE Deploys Medical Team to Colombian Border Towns to Ease Suffering of Venezuelans

Millwood, VA, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Project HOPE says it is scaling ...

author_avatar
NASDAQ Market News